GGrantIndex
← Leaderboards

Ara Nazarian

Beth Israel Deaconess Medical Center

Google Scholar ↗PubMed ↗ORCID ↗
$6,376,453
Attributed
$15,610,086
Total exposure
11
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.2M · FY2010–25
$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,610,086 · 11

By mechanism

R44$6,888,425 · 3
R01$6,547,642 · 3
R00$729,568 · 1
R56$575,973 · 1
R21$431,298 · 1
R43$256,000 · 1

Top collaborators

Most similar at Beth Israel Deaconess Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Property”

Research focus

PropertyDesignCaringStructurePainIn VivoAnimalsCollaborationsTissuesHistologicSignal TransductionProteinsBaseImageMusculoskeletalFractureComputer SoftwareSerumReportingBoneX-Ray Computed TomographyIn VitroAffectCost

Grant awards (29)

The Conundrum of Absentee Receptors: Efficacy Potentiation Through Drug-Receptor Modulation$629,586
R01 · FY2025 · AR
Sustained Release Relaxin-2 for the Treatment of Frozen Shoulder$601,723
R01 · FY2025 · AR
Software Platform for Automatic, Opportunistic Screening of Vertebral Compression Fractures$50,000
R44 · FY2025 · AG
Software Platform for Automatic, Opportunistic Screening of Vertebral Compression Fractures$986,000
R44 · FY2024 · AG
Automatic, Opportunistic Surveillance of Hip Bone Fragility in X-ray Images$918,848
R44 · FY2024 · AG
The Conundrum of Absentee Receptors: Efficacy Potentiation Through Drug-Receptor Modulation$628,970
R01 · FY2024 · AR
Sustained Release Relaxin-2 for the Treatment of Frozen Shoulder$603,668
R01 · FY2024 · AR
Automatic, Opportunistic Surveillance of Hip Bone Fragility in X-ray Images$50,000
R44 · FY2024 · AG
Software Platform for Automatic, Opportunistic Screening of Vertebral Compression Fractures$986,000
R44 · FY2023 · AG
Automatic, Opportunistic Surveillance of Hip Bone Fragility in X-ray Images$915,851
R44 · FY2023 · AG
The Conundrum of Absentee Receptors: Efficacy Potentiation Through Drug-Receptor Modulation$652,797
R01 · FY2023 · AR
Sustained Release Relaxin-2 for the Treatment of Frozen Shoulder$625,269
R01 · FY2023 · AR
The Conundrum of Absentee Receptors: Efficacy Potentiation Through Drug-Receptor Modulation$649,942
R01 · FY2022 · AR
Sustained Release Relaxin-2 for the Treatment of Frozen Shoulder$621,398
R01 · FY2022 · AR
CTRA Software Solution for Fracture Risk Assessment of Axial Skeleton$1,490,863
R44 · FY2020 · AG
Relaxin-2 as a Novel Protein Therapeutic for the Treatment of Shoulder Arthrofibrosis$575,973
R56 · FY2020 · AR
Software Solution for Clinical Management of Musculoskeletal Tumors$256,000
R43 · FY2020 · CA
CTRA Software Solution for Fracture Risk Assessment of Axial Skeleton$1,490,863
R44 · FY2019 · AG
Dissolvable Hydrogel Dressing for the Treatment of Burns$381,780
R01 · FY2019 · EB
Dissolvable Hydrogel Dressing for the Treatment of Burns$381,569
R01 · FY2018 · EB
Dissolvable Hydrogel Dressing for the Treatment of Burns$379,126
R01 · FY2017 · EB
Dissolvable Hydrogel Dressing for the Treatment of Burns$391,814
R01 · FY2016 · EB
Assessment of Bone Composition Through a Novel Liquid/Solid State MRI Method$244,019
R00 · FY2014 · AR · contact PI
Assessment of Bone Composition Through a Novel Liquid/Solid State MRI Method$236,550
R00 · FY2013 · AR · contact PI
A Portable Wound Hemostasis System Using a Hydrogel Polymeric Foam$224,130
R21 · FY2013 · EB · contact PI
Assessment of Bone Composition Through a Novel Liquid/Solid State MRI Method$248,999
R00 · FY2012 · AR · contact PI
A Portable Wound Hemostasis System Using a Hydrogel Polymeric Foam$207,168
R21 · FY2012 · EB · contact PI
Assessment of Bone Composition Through a Novel Liquid/Solid State MRI Method$89,995
K99 · FY2011 · AR · contact PI
Assessment of Bone Composition Through a Novel Liquid/Solid State MRI Method$91,185
K99 · FY2010 · AR · contact PI